In this review, we discuss the discovery and biologic significance of HE4 and evaluate available evidence regarding the utility of HE4 as a biomarker for ovarian and endometrial cancer.
Robert C. Bast, Jr, MD
Advertisement
Articles by Robert C. Bast, Jr, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Navigating the RCC Adjuvant Landscape: Examining the Phase 3 RAMPART Trial
2
84 Exceptional Responders in De Novo Metastatic Breast Cancer (dnMBC) Drug Cessation in Patients With HER2-Positive Metastatic Breast Cancer; Multicenter Retrospective Study
3
BCMA CAR T-Cell Therapy Improves OS Vs Teclistamab in Multiple Myeloma
4
Radiation Oncology Trials You May Have Missed at ASCO 2026
5